[Federal Register Volume 68, Number 139 (Monday, July 21, 2003)]
[Notices]
[Pages 43164-43165]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-18481]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated March 14, 2003, and published in the Federal 
Register on April 2, 2003, (68 FR 16088), Cedarburg Pharmaceuticals, 
LLC, 870 Badget Circle, Grafton, Wisconsin 53204, made application by 
letter to the Drug Enforcement Administration to be registered as a 
bulk manufacturer of dihydromorphine (9145), a basic class of 
controlled substance listed in Schedule I.
    The firm plans to use this substance in the conversion process to 
produce a Schedule II controlled substance, hydromorphone.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, section 823(a) and 
determined that the registration of Cedarburg Pharmaceuticals, LLC, to 
manufacture the listed controlled substances is consistent with the 
public interest at this time. DEA has investigated

[[Page 43165]]

Cedarburg Pharmaceuticals, LLC. to ensure that the company's 
registration is consistent with the public interest. This investigation 
has included inspection and testing of the company's physical security 
systems, verification of the company's compliance with state and local 
laws, and a review of the company's background and history. Therefore, 
pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy 
Assistant Administrator, Office of Diversion Control, hereby orders 
that the application submitted by the above firm for registration as a 
bulk manufacturer of the basic class of controlled substance listed is 
granted.

    Dated: July 3, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-18481 Filed 7-18-03; 8:45 am]
BILLING CODE 4410-09-M